What is the appropriate evaluation and first‑line management for constipation in an otherwise healthy adult without red‑flag symptoms?

Appropriate Evaluation and First-Line Management for Constipation in Healthy Adults

For an otherwise healthy adult without red-flag symptoms, start with polyethylene glycol (PEG) as first-line pharmacological therapy after ensuring adequate fluid intake and considering a trial of fiber supplementation for mild symptoms. 1

Initial Evaluation

History and Physical Examination

Focus on identifying:

• Stool frequency and consistency using Bristol Stool Form Scale
• Specific symptoms: straining, incomplete evacuation, hard stools, need for digital maneuvers
• Medication review to identify drug-induced constipation (opioids, anticholinergics, calcium channel blockers)
• Red-flag symptoms requiring colonoscopy: rectal bleeding, unintentional weight loss, iron deficiency anemia, family history of colorectal cancer, age >50 without screening 2
• Digital rectal examination to assess for structural abnormalities and defecatory disorders 3

Diagnostic Testing

• No routine laboratory studies or imaging are recommended in the absence of alarm symptoms 2, 4
• Colonoscopy only indicated for red-flag symptoms or overdue colorectal cancer screening 2
• Physiological testing (anorectal manometry, balloon expulsion test) reserved for patients failing first-line and second-line therapies 3, 2

First-Line Management Algorithm

Step 1: Lifestyle Modifications

• Ensure adequate fluid intake, particularly for patients in the lowest quartile of daily fluid consumption 1
• Increase physical activity (modifiable risk factor) 2
• Review and discontinue aggravating medications when possible 2

Step 2: Fiber Supplementation (Conditional First-Line)

Consider for mild constipation or in combination with PEG 1

• Psyllium has the best evidence among fiber supplements, though quality remains low 1
• Dose: Standard fiber supplements taken with 8-10 ounces of fluid 1
• Caution: Wheat bran (finely ground) can decrease stool water content and worsen symptoms 1
• Common side effect: Flatulence 1
• Evidence limitation: Studies are 30-40 years old with small sample sizes 1

Step 3: Osmotic Laxatives - Polyethylene Glycol (Strong First-Line)

PEG is the recommended first-line pharmacological agent 1

• Strength of recommendation: Strong recommendation with moderate certainty of evidence 1
• Efficacy: Response shown to be durable over 6 months 1
• Side effects: Abdominal distension, loose stool, flatulence, nausea 1
• Evidence base: Three randomized placebo-controlled trials with 429 total participants 1

Alternative osmotic laxatives (conditional recommendations):

• Lactulose 1
• Magnesium oxide 1, 5

Second-Line Therapy (If PEG Ineffective)

Brief Trial of Stimulant Laxatives

• Sodium picosulfate (strong recommendation) 1
• Senna (conditional recommendation) 1
• Bisacodyl 1
• Note: Designated for as-needed use in some guidelines 6

Secretagogues (Strong Recommendations)

• Linaclotide 1
• Plecanatide 1
• Lubiprostone (conditional recommendation) 1

Prokinetic Agent

• Prucalopride (strong recommendation, serotonin type 4 agonist) 1

Specific Food-Based Interventions with Evidence

Recent dietary guidelines provide specific recommendations 5:

• Prunes: 85% of patients report symptom relief 7
• Kiwifruits: Evidence-based recommendation 5
• Dates: 71% report relief 7
• High mineral-content water: Evidence-based recommendation 5
• Rye bread: Evidence-based recommendation 5

Common Pitfalls to Avoid

1. Do not routinely order colonoscopy without red-flag symptoms or screening indication 2, 4
2. Avoid finely ground wheat bran as it can worsen constipation 1
3. Do not use stimulant laxatives as first-line therapy; reserve for brief trials after osmotic laxatives 1, 6
4. Do not assume all fiber is equal; psyllium has better evidence than other types 1
5. Recognize that 94% of patients prefer dietary options over medication when effective 7

When to Refer to Gastroenterology

Refer for specialized testing (anorectal manometry, balloon expulsion test) when:

• Initial treatment approach with PEG and second-line agents is ineffective 2
• Strong suspicion of defecatory disorder based on symptoms (excessive straining, need for digital maneuvers) 3
• Refractory constipation despite appropriate pharmacological trials 8

Early referral for pelvic floor therapy with biofeedback if pelvic floor dysfunction identified, while continuing first-line medications 2